Author:
Giebler Antasia,Sniecinski Roman
Publisher
Springer Science and Business Media LLC
Reference69 articles.
1. • Mehta RS. Novel oral anticoagulants for prophylaxis and treatment of venous thromboembolism: part I (Factor Xa inhibitors). Expert Rev Hematol. 2010;3(2):227–41. Excellent review on the development and pharmacology of Factor Xa Inhibitors.
2. • Mehta RS. Novel oral anticoagulants. Part II: direct thrombin inhibitors. Expert Rev Hematol. (2010) 3(3):351–61. https://doi.org/10.1586/ehm.10.12. Excellent review on the development and pharmacology of direct thrombin inhibitors.
3. Iyer GS, Tesfaye H, Khan NF, Zakoul H, Bykov K. Trends in the Use of Oral Anticoagulants for Adults With Venous Thromboembolism in the US, 2010–2020. JAMA Netw Open. 2023;6(3): e234059.
4. Colacci M, Tseng EK, Sacks CA, Fralick M. Oral Anticoagulant Utilization in the United States and United Kingdom. J Gen Intern Med. 2020;35(8):2505–7.
5. Lane DA, Philippou H, Huntington JA. Directing thrombin. Blood. 2005;106(8):2605–12.